73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

January 2024Leah LawrenceNew data indicate that the use of tubes that automatically collect less blood in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions without affecting

Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

January 2024Leah LawrenceNew data indicate that the use of tubes that automatically collect less blood in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions without affecting
Pausing breast cancer treatment for pregnancy appears safe

Pausing breast cancer treatment for pregnancy appears safe

by Carla K. JohnsonThis Aug. 7, 2018 photo provided by Amy Bianchi of Albany, N.Y. shows her days before she gave birth to her son, Brayden, in Schenectady, N.Y. Credit: Courtesy Amy Bianchi via APYou

Pausing breast cancer treatment for pregnancy appears safe

by Carla K. JohnsonThis Aug. 7, 2018 photo provided by Amy Bianchi of Albany, N.Y. shows her days before she gave birth to her son, Brayden, in Schenectady, N.Y. Credit: Courtesy Amy Bianchi via APYou
Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was
Skin cancer: New therapy option to prevent metastases

Skin cancer: New therapy option to prevent metastases

byMedical University of ViennaA, Invadopodia index of MMPi treated wells normalized to DMSO control in 3 independent screening plates as indicated; B, MTS signal values of B16-F10 and WM983C cel

Skin cancer: New therapy option to prevent metastases

byMedical University of ViennaA, Invadopodia index of MMPi treated wells normalized to DMSO control in 3 independent screening plates as indicated; B, MTS signal values of B16-F10 and WM983C cel
Unfruitful: Eating more produce will not cure, stop prostate cancer

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme
Diagnosis of ovarian cancer delayed by woeful lack of awareness

Diagnosis of ovarian cancer delayed by woeful lack of awareness

by World Ovarian Cancer CoalitionA global study of women with ovarian cancer has found that two thirds of women had never heard of the disease, or did not know anything about it before their diagnosis

Diagnosis of ovarian cancer delayed by woeful lack of awareness

by World Ovarian Cancer CoalitionA global study of women with ovarian cancer has found that two thirds of women had never heard of the disease, or did not know anything about it before their diagnosis
As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl
SABCS: Long-term outcomes good for PBI in early breast cancer

SABCS: Long-term outcomes good for PBI in early breast cancer

(HealthDay)—For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI) and whole breast irradiation (WBI), according to a study prese

SABCS: Long-term outcomes good for PBI in early breast cancer

(HealthDay)—For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI) and whole breast irradiation (WBI), according to a study prese
Researchers discover source of deadly fungal infections in bone marrow transplant patients

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei
Gene signature points to prognosis in kidney cancer

Gene signature points to prognosis in kidney cancer

byKarolinska InstitutetSingle-cell landscape of the ecosystem in primary ccRCC and adjacent normal tissue.aExperimental design created with Biorender.com and Adobe Illustrator.

Gene signature points to prognosis in kidney cancer

byKarolinska InstitutetSingle-cell landscape of the ecosystem in primary ccRCC and adjacent normal tissue.aExperimental design created with Biorender.com and Adobe Illustrator.
In preclinical studies, team identifies potential therapy for metastatic colon cancer

In preclinical studies, team identifies potential therapy for metastatic colon cancer

by Weill Cornell Medical CollegeMultiplex immunofluorescence image of hyaluronan-rich human colorectal cancer. Highly aggressive tumoral cells (turquoise and magenta) are negative for both aPKCs

In preclinical studies, team identifies potential therapy for metastatic colon cancer

by Weill Cornell Medical CollegeMultiplex immunofluorescence image of hyaluronan-rich human colorectal cancer. Highly aggressive tumoral cells (turquoise and magenta) are negative for both aPKCs